Koninklijke Philips/€PHIA

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Koninklijke Philips

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Ticker

€PHIA
Sector

Primary listing

AEX

Employees

67,263

PHIA Metrics

BasicAdvanced
€23B
138.20
€0.17
0.79
€0.85
3.53%

What the Analysts think about PHIA

Analyst ratings (Buy, Hold, Sell) for Koninklijke Philips stock.

Bulls say / Bears say

Philips delivered a stronger-than-expected adjusted EBITA margin of 12.4% in Q2 versus analysts’ 9.9% estimate, driven by innovation-led product mix and productivity improvements (Reuters).
Comparable order intake grew 6% year-on-year in Q2, boosted by AI-powered diagnostic systems and a multi-year agreement with Indonesia’s Ministry of Health for the Azurion image-guided therapy platform, demonstrating strong commercial momentum (Reuters).
Philips raised its net cash flow guidance to €200–€400 million for 2025 after strong Q2 performance and reduced tariff estimates, underscoring robust cash generation potential (WSJ).
Net profit plunged 47% year-on-year to €240 million in Q2 from €452 million a year earlier, reflecting the absence of a €538 million one-off insurance gain in the prior period (WSJ).
Group sales were flat at €4.3 billion in Q2 with only 1% comparable growth year-on-year, underscoring persistent revenue headwinds in key markets (Reuters).
In May, Philips cut its full-year adjusted EBITA margin forecast to 10.8%–11.3% due to an expected €250–300 million tariff impact, highlighting ongoing geopolitical risks to profitability (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.

PHIA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PHIA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €PHIA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs